Vivos Therapeutics (VVOS) Change in Account Payables (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Change in Account Payables of $318000.0 for Q1 2026, up 191.74% year-over-year from $109000.0 in Q1 2025, and up 175.0% quarter-over-quarter from -$424000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Change in Account Payables (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Change in Account Payables for 7 consecutive years, with $318000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 191.74% year-over-year to $318000.0; the TTM figure through Mar 2026 stood at $733000.0 (up 156.69% YoY), while the FY2025 annual figure was $524000.0, up 150.0% from the prior year.
- Change in Account Payables rose to $318000.0 in Q1 2026 per VVOS's latest filing, from -$424000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $767000.0 in Q4 2022 and bottomed at -$953000.0 in Q3 2024.
- Historically, Change in Account Payables has averaged $59941.2 across 5 years, with a median of $109000.0 in 2025.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 321.43% — and 2025, when it plunged 2027.27%.
- Vivos Therapeutics' Change in Account Payables stood at $767000.0 in 2022, then slipped by 19.69% to $616000.0 in 2023, then slumped by 96.43% to $22000.0 in 2024, then slumped by 2027.27% to -$424000.0 in 2025, then soared by 175.0% to $318000.0 in 2026.
- Business Quant data shows VVOS's Change in Account Payables at $318000.0 in Q1 2026, -$424000.0 in Q4 2025, and $340000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 950,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | -424,000.00 |
| Dec 31, 2025 | -424,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 499,000.00 |
| Jun 30, 2025 | 499,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | -953,000.00 |
| Sep 30, 2024 | -953,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Mar 31, 2024 | 354,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Dec 31, 2023 | 616,000.00 |